Pan-cancer analysis of TMED2: unraveling potential immune characteristics and prognostic value in cancer therapy
Our integrated analysis suggests that targeting TMED2, along with its associated genes and signaling pathways, could represent a new strategy for cancer immune treatment.
Authors
- Zhuangzhi Wang (ORCID: https://orcid.org/0000-0003-2483-5590)
- Yuchao Gu (ORCID: https://orcid.org/0000-0002-8723-3899)
- Changning Sun (ORCID: https://orcid.org/0000-0003-2747-7717)
- Shih‐Wen Lin
- Xiao Yu Wu (ORCID: https://orcid.org/0000-0002-5333-8115)
- Pengfei Wang (ORCID: https://orcid.org/0000-0003-3279-8881)
Institutions
- Qingdao University (CN)
- Qingdao University of Science and Technology (CN)
- Affiliated Hospital of Qingdao University (CN)
- Ocean University of China (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-05-30
- DOI
- https://doi.org/10.3389/fimmu.2025.1578627
- Citations
- 1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 1.05